Candida in IBD: Friend or Foe?

5Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Cell Host & Microbe, Leonardi et al. demonstrate ulcerative colitis patients with high Candida responded best to fecal microbial transplant (FMT). However, decreased Candida post-treatment was associated with improved disease—suggesting that Candida reductions are associated with less inflammation. Pre-FMT Candida levels may identify FMT responders.

Cite

CITATION STYLE

APA

Fritsch, J., & Abreu, M. T. (2020, May 13). Candida in IBD: Friend or Foe? Cell Host and Microbe. Cell Press. https://doi.org/10.1016/j.chom.2020.04.018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free